93ce827d-6d64-470e-a438-4eb04d49a31f.jpeg

+2 more

Give topper style notes to score full marks in exam for mucoepidermoid carcinoma based on this book

analyse_media

The second image gave me all the detailed content I need. Now let me compile comprehensive topper-style notes.

MUCOEPIDERMOID CARCINOMA - TOPPER NOTES

(Chapter 7: Salivary Gland Neoplasms)

1. INTRODUCTION / DEFINITION

Malignant epithelial tumor of salivary glands
First studied and described as a separate entity by Stewart et al. in 1945
Name derived from its composition: mucus-secreting cells + epidermoid-type cells in varying proportions
Columnar cells and clear cells are also seen
Often demonstrates prominent cystic growth

2. EPIDEMIOLOGY & INCIDENCE

Feature	Detail
Most common malignant neoplasm	of both major and minor salivary glands
% of malignant salivary tumors	29-34%
% of ALL salivary gland tumors	5%
Sex predilection	Slight female predilection
Peak age	3rd or 5th decade; average age 47 years
Can occur	Virtually all decades
Most common malignant salivary gland tumor in children	YES - youngest patient reported: 20-month-old female (Adepitan A., Owosho et al.)

3. SITE OF OCCURRENCE

Most common site: Parotid gland (major gland)
Intraorally: Strong predilection for the palate (Fig. 7.19)
Other intraoral sites: buccal mucosa, tongue, retromolar areas
Minor salivary glands involved frequently
Prior exposure to ionizing radiation substantially increases risk

4. CLINICAL FEATURES

Low-grade malignancy:

Slowly enlarging, painless mass
Simulates pleomorphic adenoma
Seldom exceeds 5 cm in diameter
Not completely encapsulated
May contain cysts filled with viscid, mucoid material
Palatal lesions mimic mucocele or vascular lesions (color: blue to red/purple)
Intraoral lesions resemble mucous retention phenomenon or mucocele

High-grade malignancy:

Grows rapidly; pain may be early symptom
Facial nerve paralysis - frequent in parotid tumors
Trismus, drainage from ear, dysphagia, numbness of adjacent areas
Ulceration - especially in minor salivary gland tumors
Not encapsulated
Tends to infiltrate surrounding tissue
Metastasizes to regional lymph nodes
Distant metastases: lung, bone, brain, subcutaneous tissues

5. GENETICS (HIGH-YIELD!)

Frequently asked in exams - memorize these translocation details!

Finding	Details
t(11;19)(q21;p13)	Fusion of CRTC1-MAML2 - present in 40-90% of cases
t(11;15)(q21;q26)	Fusion of CRTC3-MAML2 - present in ~6% of cases
CDKN2A deletion	Mapped to chromosome 9p21.3 - 25% of cases

6. HISTOLOGIC FEATURES

Cell of origin: Pluripotent reserve cells of excretory ducts

Three main cell types:

Cell Type	Features
Mucous cells	Abundant pale, foamy cytoplasm; stain positively for mucin stains (Fig. 7.20A & B)
Epidermoid (squamous) cells	Squamoid features, polygonal shape, intercellular bridges, rarely keratinize
Intermediate cells	Larger than basal cells but smaller than squamous cells; believed to be progenitor of epidermoid and mucous cells; highly prolific basaloid cells
Clear cells	Clusters present occasionally; generally mucin- and glycogen-free (Fig. 7.20E)

Arrangement:

Epidermoid cells + intermediate cells + mucous cells line cystic spaces or form solid masses/cords
Epidermoid and mucous cells may be arranged in a glandular pattern
Cysts may rupture → liberate mucus → pool in connective tissue → evoke inflammatory reaction

7. GRADING (MOST IMPORTANT SECTION!)

Mucoepidermoid carcinomas are graded as low, intermediate, and high grade:

LOW-GRADE TUMORS

Well-formed glandular structures
Prominent mucin-filled cystic spaces
Minimal cellular atypia
High proportion of mucous cells (Fig. 7.21)

INTERMEDIATE-GRADE TUMORS

Solid areas of epidermoid/squamous cells with intermediate basaloid cells
Cyst formation less prominent than low-grade
All cell types present, but intermediate cells predominate

HIGH-GRADE TUMORS

Solid nests and cords of intermediate basaloid and epidermoid cells
Prominent nuclear pleomorphism and mitotic activity
Cystic component usually very less (<20%)
Glandular component rare (may occasionally predominate)
Necrosis and perineural invasion may be present

8. IMMUNOHISTOCHEMISTRY

Marker	Result
p63	Strong positive
CK5, CK6, CK7, CK8, CK14, CK18	Positive
EMA (Epithelial membrane antigen)	Positive
CEA (Carcinoembryonic antigen)	Positive

Key point (J.A. Bishop et al.): MAML2 fusion-positive mucoepidermoid carcinoma can still be negative for p40, p63, and CK 5/6 - therefore genetic changes should be considered for confirmative diagnosis

9. VARIANTS OF MUCOEPIDERMOID CARCINOMA

a) Sclerosing Mucoepidermoid Carcinoma

Extremely rare - only 6 reported cases
Characterized by intense central sclerosis occupying entirety of an otherwise typical tumor
Inflammatory infiltrate of plasma cells, eosinophils, and/or lymphocytes at periphery
Sclerosis obscures typical morphology → diagnostic difficulties
Tumor infarction and extravasation of mucin → reactive fibrosis (possible cause)

b) Intraosseous Mucoepidermoid Carcinoma

Also called Central Mucoepidermoid Carcinoma
Originates within the jaws
Formed by malignant transformation of epithelial lining of odontogenic cysts
Presents as asymptomatic radiolucent lesion
Histologically: low-grade malignancy
Mandible 3x more commonly affected than maxilla

c) Oncocytic Mucoepidermoid Carcinoma

Very rare variant
Contains >50% oncocytic cells with other features of mucoepidermoid carcinoma
Oncocytic cells: polygonal with eosinophilic granular cytoplasm

d) Sclerosing Mucoepidermoid Carcinoma with Eosinophilia

e) De-differentiated Mucoepidermoid Carcinoma

10. TREATMENT AND PROGNOSIS

Condition	Treatment
Low- and intermediate-grade (parotid)	Conservative excision with preservation of facial nerve
Submandibular gland	Removed entirely
Cervical node metastasis / T3 lesion	Radical neck dissection
Minor gland tumors	Primarily surgical
High-grade malignancies	Surgery + postoperative irradiation
High-grade (chemotherapy)	Shows sensitivity similar to squamous cell carcinoma

Prognosis (5-year cure rates):

Grade	5-year Cure Rate
Low-grade	92%
Intermediate- and High-grade	49%

11. QUICK REVISION MNEMONICS

"MEC = Most common malignant Epithelial salivary Carcinoma"

Cell types - "MIE-C" = Mucous, Intermediate, Epidermoid, Clear cells

Translocation - "19 is the KEY": t(11;19) → CRTC1-MAML2 (40-90% of cases)

Grades - "LIM": Low (cysts + mucous predominate), Intermediate (solid + all cell types), High (solid + pleomorphism + necrosis)

12. EXAM COMPARISON TABLE

Feature	Low Grade	High Grade
Growth	Slow, painless	Rapid, painful
Encapsulation	Partial	None
Cysts	Prominent	<20%
Cell atypia	Minimal	Prominent pleomorphism
Necrosis	Absent	May be present
Metastasis	Rare	To lymph nodes, lung, bone, brain
5-yr cure	92%	49%

13. KEY FACTS TO SCORE FULL MARKS

Stewart et al. 1945 - first described as separate entity
Most common malignant tumor of both major AND minor salivary glands
29-34% of all malignant salivary tumors; 5% of all salivary gland tumors
Most common malignant salivary tumor in children
t(11;19)(q21;p13) encoding CRTC1-MAML2 in 40-90% - most important translocation
Intermediate cells = most important cells for recognition - progenitor cells
Low-grade: 92% cure; High-grade: 49% cure
Intraosseous form: mandible 3x > maxilla; forms from odontogenic cyst lining
High-grade: facial nerve palsy, pain, infiltrative, necrosis, perineural invasion
IHC: p63, CK5/6, CK7, EMA, CEA positive - but MAML2 fusion+ cases can be CK5/6 and p63 negative - use genetics for confirmation

It's like a book i just wanted notes

Got it! Here are clean, concise notes:

MUCOEPIDERMOID CARCINOMA

Definition: Malignant epithelial tumor; first described by Stewart et al. (1945) Composition: Mucus-secreting cells + epidermoid cells + clear cells + columnar cells

EPIDEMIOLOGY

Most common malignant tumor of major & minor salivary glands
29-34% of malignant salivary tumors; 5% of all salivary gland tumors
Most common malignant salivary tumor in children
Slight female predilection; peak age 3rd or 5th decade (avg. 47 yrs)

SITE

Most common: Parotid gland
Intraorally: Palate (most common)
Also: buccal mucosa, tongue, retromolar area
Risk factor: Ionizing radiation

CLINICAL FEATURES

Low-grade → slow, painless, simulates pleomorphic adenoma, cystic, <5 cm, palatal lesions mimic mucocele (blue-red-purple)

High-grade → rapid growth, pain, facial nerve paralysis, ulceration, not encapsulated, metastasizes to lymph nodes, lung, bone, brain

GENETICS

Translocation	Fusion	Frequency
t(11;19)(q21;p13)	CRTC1-MAML2	40-90%
t(11;15)(q21;q26)	CRTC3-MAML2	~6%
CDKN2A deletion	Chr 9p21.3	25%

HISTOLOGY

Origin: Pluripotent reserve cells of excretory ducts

Cell types:

Mucous cells - pale, foamy, mucin+
Epidermoid cells - polygonal, intercellular bridges, rarely keratinize
Intermediate cells - between basal & squamous; progenitor of mucous & epidermoid cells (key cells for diagnosis)
Clear cells - mucin & glycogen free

GRADING

	Low	Intermediate	High
Cysts	Prominent	Less prominent	<20%
Predominant cell	Mucous	Intermediate	Epidermoid/basaloid
Atypia	Minimal	Moderate	Marked pleomorphism
Necrosis	Absent	Absent	May be present

IHC

Positive: p63, CK5, CK6, CK7, CK8, CK14, CK18, EMA, CEA

If MAML2 fusion+, can still be negative for p63, p40, CK5/6 → use genetics for confirmation

VARIANTS

Sclerosing - intense central sclerosis, plasma cells/eosinophils at periphery; only 6 cases reported
Intraosseous (Central) - from odontogenic cyst lining; radiolucent; mandible 3x > maxilla; low-grade
Oncocytic - >50% oncocytic cells; eosinophilic granular cytoplasm

TREATMENT & PROGNOSIS

Low/intermediate (parotid): Conservative excision + preserve facial nerve
Submandibular: Remove entirely
T3/node+: Radical neck dissection
High-grade: Surgery + postoperative irradiation; chemo sensitivity similar to SCC

Grade	5-year cure
Low	92%
Intermediate + High	49%

This is a shared conversation. Sign in to Orris to start your own chat.